- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Q2 2021 Novo Nordisk A/S Earnings Call Transcript
Hello, and welcome to Novo Nordisk A/S First 6 Months of 2021 Results Conference Call.
(Operator Instructions)
Today, I'm pleased to present Lars Fruergaard Jørgensen, CEO. Please go ahead with your meeting.
/- -
Thank you very much, and welcome to this Novo Nordisk earnings call for the first 6 months of 2021 and the outlook for the year. I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk.
I'd like to start by thanking you for your scheduling flexibility today as we decided to advance this earnings call as a consequence of our earlier-than-anticipated release of our results following an upgrade of both sales and operating profit.
With me today, I have our Chief Financial Officer, Karsten Munk Knudsen; Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest; Executive Vice President and Head of North America Operations, Doug Langa; and finally,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |